glp-1 drugs tirzepatide GLP-1/GIP Rx How Does Tirzepatide Work? |
Description
Oral GLP-1 currently represented by Rybelsus (oral semaglutide 7mg/14mg daily) for T2DM and advanced by Eli Lilly's orforglipron in late-stage trials is growing at the fastest route of administration CAGR because it fundamentally removes the injection barrier that constrains GLP-1 therapy adoption in the substantial patient population for whom daily or weekly self-injection is a genuine disincentive to treatment initiation or maintenance

Additionally, the appetite-suppressing effects of GLP-1 medications can partially attenuate over time as receptors adjust to sustained stimulation

Overall, our GLP-1 thesis is still sound and right for the right reasons

Systemic metabolic benefits

We don't know yet," according to NBC News coverage

The primary outcome was defined as MACE
